BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 27418274)

  • 1. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.
    Yoon YK; Park DW; Sohn JW; Kim HY; Kim YS; Lee CS; Lee MS; Ryu SY; Jang HC; Choi YJ; Kang CI; Choi HJ; Lee SS; Kim SW; Kim SI; Kim ES; Kim JY; Yang KS; Peck KR; Kim MJ
    BMC Infect Dis; 2016 Jul; 16():331. PubMed ID: 27418274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. agr functionality affects clinical outcomes in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia.
    Kang CK; Kim YK; Jung SI; Park WB; Song KH; Park KH; Choe PG; Jang HC; Lee S; Kim YS; Kwak YG; Kwon KT; Kiem S; Kim CJ; Kim ES; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2187-2191. PubMed ID: 28639163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia.
    Kim T; Chong YP; Park KH; Bang KM; Park SJ; Kim SH; Jeong JY; Lee SO; Choi SH; Woo JH; Kim YS
    Korean J Intern Med; 2019 Jan; 34(1):184-194. PubMed ID: 28859468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
    Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
    Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
    Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
    J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
    J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
    Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
    Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
    Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
    Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
    J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
    Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
    J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
    Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
    Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
    Honda H; Doern CD; Michael-Dunne W; Warren DK
    BMC Infect Dis; 2011 Dec; 11():335. PubMed ID: 22142287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.